Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

3.04
Delayed Data
As of 11:27am ET
 +0.05 / +1.67%
Today’s Change
1.41
Today|||52-Week Range
3.37
+30.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues13.5M14.2M12.0M13.4M
 
 
 
 
 
Cost of Goods Sold7.6M6.2M5.7M5.1M
 
 
 
 
 
Depreciation And Amortization480.2K489.1K493.7K477.8K
 
 
 
 
 
 
Operating ExpensesGross Income5.4M7.5M5.8M7.8M
 
 
 
 
 
General Expenses11.6M11.7M10.6M10.5M
 
 
 
 
 
Research And Development6.0M5.6M3.1M3.2M
 
 
 
 
 
Total Operating Expenses19.6M18.4M16.8M16.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-4.2M-4.8M-2.7M
 
 
 
 
 
Other Expenses15.5K-181.0K29.9K-120.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.1M-4.4M-4.7M-2.8M
 
 
 
 
 
Income Taxes0.00-100.0K0.000.00
 
 
Net Income-6.1M-4.5M-4.7M-2.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.1M155.1M155.2M155.9M
 
 
 
 
 
Shares To Calculate EPS Diluted155.1M155.1M155.2M155.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.03-$0.03-$0.02
 
 
 
 
 
EPS Diluted-$0.04-$0.03-$0.03-$0.02